These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8749729)

  • 1. Treatment of alcohol and cocaine addiction by the combination of pemoline and fenfluramine: a preliminary case series.
    Rothman RB
    J Subst Abuse Treat; 1995; 12(6):449-53. PubMed ID: 8749729
    [No Abstract]   [Full Text] [Related]  

  • 2. Pemoline for the treatment of cocaine dependence in methadone-maintained patients.
    Margolin A; Avants SK; Kosten TR
    J Psychoactive Drugs; 1996; 28(3):301-4. PubMed ID: 8895115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The combination of phentermine and fenfluramine reduced cocaine withdrawal symptoms in an open trial.
    Kampman KM; Rukstalis M; Pettinati H; Muller E; Acosta T; Gariti P; Ehrman R; O'Brien CP
    J Subst Abuse Treat; 2000 Jul; 19(1):77-9. PubMed ID: 10867304
    [No Abstract]   [Full Text] [Related]  

  • 4. Combined serotonin and dopamine indirect agonists correct alcohol craving and alcohol-associated neuroses.
    Hitzig P
    J Subst Abuse Treat; 1994; 11(5):489-90. PubMed ID: 7869471
    [No Abstract]   [Full Text] [Related]  

  • 5. Combination of the dopaminergic agent, phentermine, and the serotonergic agent, fenfluramine, in the treatment of cocaine dependence.
    Kampman KM; Volpicelli J
    J Subst Abuse Treat; 1997; 14(4):401-4. PubMed ID: 9368218
    [No Abstract]   [Full Text] [Related]  

  • 6. Pemoline augmentation for resistant depression.
    Benazzi F
    J Psychiatry Neurosci; 1997 Jan; 22(1):71. PubMed ID: 9002395
    [No Abstract]   [Full Text] [Related]  

  • 7. Early augmentation of sertraline with methylphenidate.
    Postolache TT; Rosenthal RN; Hellerstein DJ; Aromin R; Kelton GM; Muran JC; Londono JH
    J Clin Psychiatry; 1999 Feb; 60(2):123-4. PubMed ID: 10084641
    [No Abstract]   [Full Text] [Related]  

  • 8. Do the endocrine and subjective effects of d-fenfluramine predict response to selective serotonin reuptake inhibitors?
    Park SB; Williamson DJ; Cowen PJ
    Int Clin Psychopharmacol; 1995 Nov; 10(4):215-20. PubMed ID: 8748042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pemoline in ADHD.
    Winsberg B; Barbato M
    J Am Acad Child Adolesc Psychiatry; 1997 Dec; 36(12):1649-50. PubMed ID: 9401321
    [No Abstract]   [Full Text] [Related]  

  • 10. Dopaminergic agents and stimulants as antidepressant augmentation strategies.
    Nierenberg AA; Dougherty D; Rosenbaum JF
    J Clin Psychiatry; 1998; 59 Suppl 5():60-3; discussion 64. PubMed ID: 9635549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine/serotonin releasers as medications for stimulant addictions.
    Rothman RB; Blough BE; Baumann MH
    Prog Brain Res; 2008; 172():385-406. PubMed ID: 18772043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venlafaxine augmentation with methylphenidate for treatment-refractory depression: a case report.
    Bader GM; Hawley JM; Short DD
    J Clin Psychopharmacol; 1998 Jun; 18(3):255-6. PubMed ID: 9617988
    [No Abstract]   [Full Text] [Related]  

  • 13. Occurrence and management of depression in the context of naltrexone treatment of alcoholism.
    Farren CK; O'Malley SS
    Am J Psychiatry; 1999 Aug; 156(8):1258-62. PubMed ID: 10450269
    [No Abstract]   [Full Text] [Related]  

  • 14. Psychostimulant augmentation during treatment with selective serotonin reuptake inhibitors in men with paraphilias and paraphilia-related disorders: a case series.
    Kafka MP; Hennen J
    J Clin Psychiatry; 2000 Sep; 61(9):664-70. PubMed ID: 11030487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of fenfluramine challenge on cocaine craving in addicted male users.
    Buydens-Branchey L; Branchey M; Hudson J; Rothman M; Fergeson P; McKernin C
    Am J Addict; 1998; 7(2):142-55. PubMed ID: 9598218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of selective serotonin reuptake inhibitors in treating alcoholic subtypes.
    Pettinati HM
    J Clin Psychiatry; 2001; 62 Suppl 20():26-31. PubMed ID: 11584872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The number of previous depressive episodes is positively associated with cortisol response to fenfluramine administration.
    Sher L; Oquendo MA; Galfalvy HC; Cooper TB; Mann JJ
    Ann N Y Acad Sci; 2004 Dec; 1032():283-6. PubMed ID: 15677429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylphenidate and SSRI-Induced sexual side effects.
    Roeloffs C; Bartlik B; Kaplan PM; Kocsis JH
    J Clin Psychiatry; 1996 Nov; 57(11):548. PubMed ID: 8968307
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-acting stimulants for the treatment of attention-deficit disorder in cocaine-dependent adults.
    Castaneda R; Levy R; Hardy M; Trujillo M
    Psychiatr Serv; 2000 Feb; 51(2):169-71. PubMed ID: 10654994
    [No Abstract]   [Full Text] [Related]  

  • 20. Psychopharmacology of ADHD: children and adolescents.
    Findling RL; Dogin JW
    J Clin Psychiatry; 1998; 59 Suppl 7():42-9. PubMed ID: 9680052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.